Economic evaluation of mental health care interventions. A review

Health Economics

Volumn 6, Issue 2, 1997, Pages 161-177

  Evers, S M A A ^a   Van Wijk, A S ^a   Ament, A J H A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Economic evaluation; Mental health care; Review

Indexed keywords

ARTICLE; ECONOMIC ASPECT; ECONOMIC EVALUATION; HEALTH CARE COST; MENTAL HEALTH CARE; METHODOLOGY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RELIABILITY;

CANADA; COSTS AND COST ANALYSIS; EPIDEMIOLOGIC METHODS; GREAT BRITAIN; HEALTH SERVICES RESEARCH; HUMANS; MENTAL HEALTH SERVICES; PROGRAM EVALUATION; QUALITY-ADJUSTED LIFE YEARS; RESEARCH DESIGN; UNITED STATES;

EID: 0030903024     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1050(199703)6:2<161::AID-HEC258>3.0.CO;2-I     Document Type: Article

References (161)

1. Conley, R. W., Conwell, M. and Arill, M. B. An approach to measuring the cost of mental illness. American Journal of Psychiatry 1967; 124: 755-62.
2. Eisenberg, J. M. Clinical economics; A guide to the economic analysis of clinical practices. Journal of the American Medical Association 1989; 262: 2879-86.
3. Fried, B. J., Worthington, C. and Deber, R. B. Economic evaluations in the Canadian mental health system II: from theory to practice in mental health care. Canadian Journal of Psychiatry 1989; 34: 637-40.
4. Drummond, M. F. Survey of cost-effectiveness and cost-benefit analyses in industrialized countries. World Health Statistics Quarterly 1985; 38: 383-401.
5. Drummond, M. F., Stoddart, G., Labelle, R. and Cushman, R. Health economics: An introduction for clinicians. Annals of Internal Medicine 1987; 107: 88-92.
6. Elixhauser, A., Luce, B. R., Taylor, W. R. and Reblando, J. Health care CBA/CEA: An update on the growth and composition of the literature. Medical Care 1993; 31: JS1-JS11 supplement.
7. Udvarhelyi, I. S., Colditz, G. A., Rai, A. and Epstein, A. M. Cost-effectiveness and cost-benefit analysis in the medical literature. Annals of Internal Medicine 1992; 116: 238-45.
8. Warner, K. E. and Hutton, R. C. Cost-benefit and cost-effectiveness analysis in health care: Growth and composition of the literature. Medical Care 1980; 18: 1069-84.
9. Association for Research into Costs and Assessment in Psychiatry. The Costs of Schizophrenia, 1990; The Costs of Affective Disorders, 1992; The Economics of Schizophrenia, Depression, Anxiety, Dementias, 1994.
10. British Journal Psychiatry 1995: 166: 52-9 supplement.
11. Frank, R. G. and Manning, W. G. Economics and Mental Health. London: Johns Hopkins Press, 1992.
12. Frank, R. Cost-benefit analysis in mental health care. A review of the literature. Administration in Mental Health 1991; 8: 161-75.
13. Goldberg, D. Cost-effectiveness studies in the treatment of schizophrenia: a review. Social Psychiatry and Psychiatric Epidemiology 1991; 26: 139-42.
14. Jönsson, B. and Rosenbaum, J. Health Economics of Depression. Chichester: Wiley, 1993.
15. Rupp, A. and Keith, S. J. The costs of schizophrenia, assessing the burden. Psychiatric Clinics North America 1993; 16: 413-23.
16. Schwefel, D., Zöllner, H. and Potthoff, P. Cost and Effects of Managing Chronic Psychotic Patients. Berlin: Springer. 1988.
17. Schizophrenia Bulletin 1991; 17: 3.
18. Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A. and Mason, J. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. British Medical Journal 1993; 306: 683-7.
19. Wells, K. B. Cost containment and mental health outcomes: experiences from US studies. British Journal of Psychiatry 1995; 166: 43-51 supplement.
20. Department of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Centre. How to read clinical journals: VII. To understand an economic evaluation (part A). Canadian Medical Association Journal 1984; 130: 1428-34.
21. Department of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Centre. How to read clinical journals: VII. To understand an economic evaluation (part B). Canadian Medical Association Journal 1984; 130: 1542-9.
22. Doubilet, P., Weinstein, M. C. and McNeil, B. J. Use and misuse of the term 'cost effective' in medicine. New England Journal of Medicine 1986; 314: 253-6.
23. Drummond, M. F., Stoddart, G. L. and Torrance, G. W. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1987.
24. Drummond, M., Brandt, A., Luce, B. and Rovira, J. Standardizing methodologies for economic evaluation in health care; practice, problems and potential. International Journal of Technology Assessment in Health Care 1993; 9: 26-35.
25. Gerard, K. Cost-utility in practice: A policy maker's guide to the state of the art. Health Policy 1992; 21: 249-79.
26. Luce, B. R. and Elixhauser, A. Standards for Socioeconomic Evaluation of Health Care Products and Services. Berlin: Springer, 1990.
27. Bouter, L. M. and Ter Riet, G. Meta-analyse van therapeutische experimenten I, bronnen van vertekening. Tijdschrift voor Sociale Gezondheidszorg, Gezondheid en Samenleving 1990; 68: 179-85.
28. ter Riet, G. and Bouter, L. M. Meta-analyse van therapeutische experimenten II, voorstel tot een protocol. Tijdschrift voor Sociale Gezondheidszorg, Gezondheid en Samenleving 1990; 68: 186-9.
29. ter Riet, G., Kleijnen, J. and Knipschild, P. De meta-analyse als review-methode. Huisarts en Wetenschappen 1989; 32: 176-81.
30. Fletcher, R. H., Fletcher S. W. and Wagner E. H. Clinical Epidemiology, the essentials. Baltimore: Williams & Wilkins, 1988.
31. Kleinbaum, D. G., Kupper L. L. and Morgenstern H. Epidemiologic Research, Principles and Quantitative Methods. New York: Van Nostrand Reinhold, 1982.
32. Kleijnen, J. Food Supplements and Their Efficacy. Thesis, Maastricht, 1991.
33. Knapp. M. and Beecham, J. Reduced list costings: examination of an informed short cut in mental health care research. Health Economics 1993; 2: 313-22.
34. Maynard, A. Cost management: the economist's viewpoint. British Journal of Psychiatry 1993: 163: 7-13 supplement.
35. Pocock, S. J. Clinical Trials, a Practical Approach. Chichester: Wiley, 1993.
36. Rosenheck, R., Neale, M. and Frisman, L. Issues in estimating the costs of innovative mental health programs. Psychiatrics Quarterly 1995; 66: 9-31.
37. Sackett, D. L., Haynes, R. B. and Tugwell, P. How to Read a Clinical Journal in Clinical Epidemiology, a Basic Science for Clinical Medicine. Boston: Little, Brown, 1985.
38. Sackett, D. L. Bias in analytic research. Journal of Chronic Diseases 1979; 32: 51-63.
39. Yates, B. T. Towards the incorporation of costs, cost-effectiveness analysis and cost-benefit analysis into clinical research. Journal of Consulting and Clinical Psychology 1994; 62: 729-36.
40. Evers, S. M. A. A., van Wijk, A. S. and Ament, A. J. H. A. Economic Evaluation of Mental Health Care Interventions; a Review. Maastricht: University of Limburg, Department of Health Economics, Working Paper 94-03, 1994.
41. Health economics. Economic evaluation bibliography. Health Economics, supplement, December 1992.
42. Creed, F. and Marks, B. Liaison psychiatry in general practice: a comparison of the liaisonattachment scheme and shifted outpatient clinic models. Journal of the Royal College General Practitioners 1989; 39: 514-7.
43. Edlund, M. J. The economics of anxiety. Psychiatric Medicine 1990; 8: 15-26.
44. Hobbs, T. Toilet training people with profound mental retardation: a cost-effective procedure for large residential settings. Behavioral Engineering 1985; 9: 50-7.
45. Hughes, S. L., Cummings, J., Weaver, F., Manheim, L., Braun, B. and Conrad, K. A randomized trial of the cost effectiveness of VA hospital-based home care for the terminally ill. Health Services Research 1992; 26: 801-17.
46. Jacobs, D. F. Cost-effectiveness of specialized psychological programs for reducing hospital stays and outpatient visits. Journal of Clinical Psychology 1987; 47: 729-35.
47. Klagsbrun, S. C., Reibel, J. S. and Peircey, M. C. Cost-effective tertiary care. Psychiatric Clinics of North America 1987; 10: 207-18.
48. Murphy, J. G. and Datei, W. E. A cost-benefit analysis of community versus institutional living. Hospital and Community Psychiatry 1976; 27: 165-70.
49. Winegar, N., Bistline. J. L. and Sheridan, S. Implementing a group-therapy program in a managed-care setting C combining cost-effectiveness and quality of care. Families in society. Journal of Contemporary Human Services 1992; 73: 56-8.
50. Morss, S. E. and Lenert, L. A. Clozapine safety and cost-effectiveness: a decision analytic perspective. Medical Decision Making 1991; 11: 334.
51. Weisbrod, B. A., Test, M. A. and Stein, L. I. Alternative to mental hospital treatment II, Economic benefit-cost analysis. Archives of General Psychiatry 1980; 37: 400-5.
52. Weisbrod, B. A. Benefit-cost analysis of a controlled experiment: treating the mentally ill. Journal of Human Resources 1981; 16: 523-48.
53. Weisbrod, B. A. A guide to benefit-cost analysis, as seen through a controlled experiment in treating the mentally ill. Journal of Health Politics, Policy and Law 1983; 7: 808-45.
54. Burns, T., Raftery, J., Beadsmoore, A., McGuigan, S. and Dickson, M. A controlled trial of home-based acute psychiatric services: II. Treatment patterns and costs. British Journal of Psychiatry 1993: 163: 55-61.
55. Burns, T. and Raftery, J. Cost of schizophrenia in a randomized trial of home-based treatment. Schizophrenia Bulletin 1991; 17: 407-10.
56. Fenton, F. R., Tessier, L., Struening, E. L., Snith, F. A., Benoit, C., Contandriopoulous, A. P. and Nguyer, A. P. A 2 year follow-up of a comparative trial of the cost-effectiveness of home and hospital psychiatric treatment. Canadian Journal of Psychiatry 1984; 29: 205-11.
57. Fenton, F. R., Tessier, L., Contandriopoulous, A. P., Nguyer, A. P. and Struening, E. L. A comparative trial of home and hospital psychiatric treatment: financial costs. Canadian Journal of Psychiatry 1982; 27: 177-87.
58. Häfner, H. and van der Heiden, W. Effectiveness and cost of community care for schizophrenic patients. Hospital and Community Psychiatry 1989; 40: 59-63.
59. Häfner, H. and van der Heiden, A. The evaluation of mental health care systems. British Journal of Psychiatry 1989; 155: 12-7.
60. Rost, K., Kashner, T. M. and Smith, R. G., Jr. Effectiveness of psychiatric intervention with somatization disorder patients: improved outcomes at reduced costs. General Hospital Psychiatry 1994; 16: 381-7.
61. Smith, G. R., Jr., Rost, K. and Kashner, T. M. A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatizing patients. Archives of General Psychiatry 1995; 52: 238-43.
62. Stein, L. I. and Test, M. A. Alternatives to mental hospital treatment, I Conceptual Model, Treatment Program and Clinical Evaluation. Archives of General Psychiatry 1980; 37: 392-7.
63. Test, M. A. and Stein, L. I. Alternative to mental hospital treatment III social costs. Archives of General Psychiatry 1980; 37: 409-12.
64. Wiersma, D., Kluiter, H., Nienhuis, F. J., Ruphan, M. and Giel, R. Costs and benefits of hospital and day treatment with community care of affective and schizophrenic disorders. British Journal of Psychiatry 1995; 166: 52-9 supplement.
65. Wiersma, D., Kluiter, H., Nienhuis, F. J. and Ruphan, M. Costs and benefits of day treatment with community care for schizophrenic patients. Schizophrenia Bulletin 1991; 17: 411-9.
66. Davies, L. M. and Drummond, M. F. The economic burden of schizophrenia. Psychiatric Bulletin 1990; 14: 522-5.
67. Delaney, J. A., Seidman, E. and Willis, G. Crisis interventions and the prevention of institutionalization: an interrupted time series analysis. American Journal of Community Psychology 1978; 6: 33-45.
68. Jones, R., Goldberg, D. and Hughes, B. A comparison of two different services treating schizophrenia: a cost-benefit approach. Psychological Medicine 1980; 10: 493-505.
69. Revicki, D. A., Luce, B. R., Weschler, J. M., Brown, R. E. and Adler, M. A. Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients. Hospital and Community Psychiatry 1990; 41: 850-4.
70. Salvador-Carulla, L., Segui, J., Fernandez-Cano, P. and Canet, J. Costs and offset effect in panic disorders. British Journal of Psychiatry 1995; 166: 23-8 supplement.
71. Vinokur, A. D., van Ryn, M., Gramlich, E. M. and Price, R. H. Long-term follow-up and benefit-cost analysis of the Jobs Program: a preventive intervention for the unemployed. Journal of Applied Psychology 1991; 76: 213-9.
72. Endicott I, Herz M. I. and Gibbon M. Brief versus standard hospitalization: the differential costs. American Journal of Psychiatry 1978; 135: 707-12.
73. Drummond, M. F., Mohide, E. A., Tew, M., Streiner, D. L., Pringle, D. M. and Gilbert, J. R. Economic evaluation of a support program for caregivers of demented elderly. International Journal of Technology Assessment in Health Care 1991; 7: 209-19.
74. Kamlet, M. S., Paul, N., Greenhouse, J., Kupfer, D., Frank, E. and Wade, M. Cost utility analysis of maintenance treatment for recurrent depression. Controlled Clinical Trials 1995; 16: 17-40.
75. Simmons, S. A., Perry, P. J., Rickert, E. D. and Browne, J. L. Cost-benefit analysis of prospective pharmacokinetic dosing of nortriptyline in depressed inpatients. Journal of Affective Disorders 1985; 8: 47-53.
76. Honigfeld, G. and Patin, J. A two year clinical and economic of follow-up patients on clozapine. Hospital and Community Psychiatry 1990; 41: 882-5.
77. ten Horn, G. H. M. M. and Giel, R. The feasibility of cost-benefit studies of mental health care, an attempt with a Dutch case register. Acta Psychiatrica Scandinavica 1984; 69: 80-7.
78. Hyde, C., Bridges, K., Goldberg, D., Lowson, K., Sterling, C. and Faragher, B. The evaluation of a hostel ward. A controlled study using modified cost-benefit analysis. British Journal of Psychiatry 1987; 151: 805-12.
79. Lobeck, F., Walter, T. T. and Bobinet, D. D. The cost-effectiveness of a clinical pharmacy service in an outpatient mental health clinic. Hospital and Community Psychiatry 1989; 40: 643-5.
80. Prentky, R. and Burgess, A. W. Rehabilitation of child molesters: a cost-benefit analysis. American Journal of Orthopsychiatrics 1990; 60: 108-17.
81. Doubilet, P., Weinstein, M. C. and McNeil, B. J. Use and misuse of the term 'cost effective' in medicine. New England Journal of Medicine 1986; 314: 253-6.
82. Andrews, G., Hall, W., Goldstein, G., Lapsley, H., Bartels, R. and Silove, D. The economic costs of schizophrenia. Archives of General Psychiatry 1985; 42: 537-43.
83. Braddock, D. Community mental health and mental retardation services in the United States: A comparative study of resource allocation. American Journal of Psychiatry 1992; 149: 175-83.
84. Evers, S. M. A. A. and Ament, A. J. H. A. Costs of schizophrenia in The Netherlands. Schizophrenia Bulletin 1995; 21: 141-53.
85. Greenberg, P. E., Stiglin, L. E., Finkelstein, S. N. and Berndt, E. R. The economic burden of depression in 1990. Journal of Clinical Psychiatry 1993; 54: 405-18.
86. Gunderson, J. G. and Mosher, L. R. The cost of schizophrenia. American Journal of Psychiatry 1975; 132: 901-6.
87. Hu, T.-W., Snowden, L. R. and Jerrell, J. M. Costs and use of public mental health services by ethnicity. Journal of Mental Health Administration 1992; 19: 278-87.
88. Jönsson, B. and Bebbington, P. E. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. British Journal of Psychiatry 1994; 164: 665-73.
89. Leon, A. C., Portera, L. and Weissman, M. A. The social costs of anxiety disorders. British Journal of Psychiatry 1995; 166: 19-22 supplement.
90. Rice, D. P. and Miller, L. S. The economic burden of affective disorders. British Journal of Psychiatry 1995; 166: 34-42 supplement.
91. Ross, C. A. and Dua, V. Psychiatric health care costs of multiple personality disorder. American Journal Psychotherapy 1993; 47: 103-12.
92. Souêtre, E., Lozet, H., Cimarosti, I., Martin, P., Chignon, J. M., Ades, J., Tignol, J. and Darcourt, G. Cost of anxiety disorders: impact of comorbidity. Journal of Psychosomatic Research 1994; 38: 151-60 supplement.
93. Stoudemire, A., Frank, R., Hedemark, N., Kamlet, M. and Blazer, D. The economic burden of depression. General Hospital Psychiatry 1986; 8: 387-94.
94. Sheldon, T. A. Problems of using modelling in the economic evaluation of health care. Health Economics 1996; 5: 1-11.
95. Rutten-van Mölken, M. P. M. H., Van Doorslaer, E. K. A. and Rutten, F. F. H. Economic appraisal of asthma and COPD care: a literature review 1980-1991. Social Science and Medicine 1992; 35: 161-75.
96. Isaac, M. K. and Kapur, R. L. A cost-effectiveness analysis of three different methods of psychiatric case findings in the general population. British Journal of Psychiatry 1980; 137: 540-6.
97. Sen, B., Wilkinson, G. and Mari, J. J. Psychiatric morbidity in primary health care. A two-stage screening procedure in developing countries: choice of instruments and cost-effectiveness. British Journal of Psychiatry 1987; 151: 33-8.
98. Sheline, Y. and Kehr, C. Cost and utility of routine admission laboratory testing for psychiatric inpatients. General Hospital Psychiatry 1990; 12: 329-34.
99. Sox, H. C., Jr, Koran, L. M., Sox, C. H., Marton, K. I., Dugger, F. and Smith, T. A medical algorithm for detecting physical disease in psychiatric patients. Hospital and Community Psychiatry 1989; 40: 1270-6.
100. Diamond, R. J., Alexander, A. A. and Marshall, J. R. Economic grand rounds. A chronic psychiatric patient in an HMO. Hospital and Community Psychiatry 1985; 36: 239-41.
101. Burton, W. N., Hoy, D. A., Bonin, R. L. and Gladstone, L. Quality and cost-effective management of mental health care. Journal of Occupational Medicine 1989; 31: 363-7.
102. Moscarelli, M., Capri, S. and Neri, L. Cost evaluation of chronic schizophrenic patients during the first 3 years after the first contact. Schizophrenia Bulletin 1991; 17: 421-6.
103. Brodaty, H. and Peters, K. E. Cost effectiveness of a training program for dementia carers. International Psychogeriatrics 1991; 3: 11-22.
104. Chapman, J. R. Techniques of economic analysis in psychiatric practice. British Journal of Medical Psychology 1979; 52: 91-7.
105. O'Donnell, O., Maynard, A. and Wright, K. The Economic Evaluation of Mental Health Care: a Review. York: University of York: Centre for Health Economics Health Economics Consortium, Discussion Paper 51, December 1988.
106. Kivlahan, D. R., Heiman, J. R., Wright, R. C., Mundt J. W. and Shupe J. A. Treatment cost and rehospitalization rate in schizophrenic outpatients with a history of substance abuse. Hospital and Community Psychiatry 1991; 42: 609-14.
107. McCrone, P., Beecham, J. and Knapp, M. Community psychiatric nurse teams: Cost-effectiveness of intensive support versus generic care. British Journal of Psychiatry 1994; 165: 218-21.
108. Quinlivan, R., Hough, R., Crowell, A., Beach, C., Hofstetter, R. and Kenworthy, K. Service utilization and costs of care for severely mentally ill clients in an intensive case management program. Psychiatric Services 1995; 46: 365-71.
109. Sharfstein, S. S. and Nafziger, J. C. Community care: costs and benefits for a chronic patient. Hospital and Community Psychiatry 1976; 27: 170-3.
110. Linn, M. W., Gurel, L., Williford, W. O., Overall, J., Gurland, B., Laughlin, P. and Barchiesi, A. Nursing home care as an alternative to psychiatric consultation, a veteran administration cooperative study. Archives of General Psychiatry 1985; 42: 544-51.
111. Santos, A. B., Trasher, J. W. and Ballenger, J. C. Decentralized services for public hospital patients: a cost analysis. Hospital and Community Psychiatry 1988; 39: 827-29.
112. Grizenko, N. and Papineau, D. A comparison of the cost-effectiveness of day treatment and residential treatment for children with severe behaviour problems. Canadian Journal of Psychiatry 1992; 37: 393-400.
113. Knapp, M., Beecham, J., Koutsogeorgopoulou, V., Hallam, A., Fenyo, A., Marks, I. M., Connolly, J., Audini, B. and Muijen, M. Service use and costs of home-based versus hospital-based care for people with serious mental illness. British Journal of Psychiatry 1994; 165: 195-203.
114. Rappaport, M., Goldman, H., Thornton, P., Stegner, B., Moltzen, S., Hall, K., Gurevitz, H. and Attkisson, C. C. A method for comparing two systems of acute 24-hour psychiatric care. Hospital and Community Psychiatry 1987; 38: 1091-5.
115. Dickey, B., Cannon, N. L., McGuire, T. G. and Gudeman, J. E. The Quarterway House: A two-year cost study of an experimental residential program. Hospital and Community Psychiatry 1986; 37: 1136-43.
116. Levenson, J. L., Hamer, R. M. and Rossiter, L. F. A randomized controlled study of psychiatric consultation guided by screening in general medical inpatients. American Journal of Psychiatry 1992; 149: 631-7.
117. Rupp, A. The economic consequences of not treating depression. British Journal of Psychiatry 1995; 166: 29-33 supplement.
118. Ginsberg, G. and Marks, I. Costs and benefits of behavioural psychotherapy: a pilot study of neurotics treated by nurse-therapists. Psychological Medicine 1977; 7: 685-700.
119. Hengeveld, M. W., Ancion, F. A. J. M. and Rooijmans, H. G. M. Psychiatric consultation with depressed medical inpatients: a randomised controlled cost-effectiveness study. Internal Journal of Psychiatry in Medicine 1988; 18: 33-43.
120. Levitan S. J. and Kornfield D. S. Clinical and cost benefit liaison psychiatry. American Journal of Psychiatry 1981; 138: 790-3.
121. Bond, G. R., Miller, L. D., Krumwied, R. D. and Ward, R. S. Assertive case management in three CMHCs: a controlled study. Hospital and Community Psychiatry 1988; 39: 411-8.
122. Gillis, L. S., Koch, A. and Joyi, M. The value and cost-effectiveness of a home-visiting programme for psychiatric patients. South African Medical Journal 1990; 17: 309-10.
123. Glick, I. D., Fleming, L., DeChillo, N., Meyerkopf, N., Jackson, C., Muscara, D. and Good-Ellis, M. A controlled study of transitional day care for nonchronically-ill patients. American Journal of Psychiatry 1986; 143: 1551-6.
124. Guilette, W., Crowley, B., Savitz, S. A. and Goldberg, F. D. Day hospitalization as a cost-effective alternative to inpatient care: a pilot study. Hospital and Community Psychiatry 1978; 29: 525-7.
125. Hu, T. and Jerell, J. Cost-effectiveness of alternative approaches in treating severely mentally ill in California. Schizophrenia Bulletin 1991; 17: 461-8.
126. Jerrell, J. M. and Hu, T. Cost-effectiveness of intensive clinical and case management compared with an existing system of care. Inquiry 1989; 26: 224-34.
127. Jones, K., Colson, P., Valencia, E. and Susser, E. A preliminary cost effectiveness analysis of an intervention to reduce homelessness among the mentally ill. Psychiatric Quarterly 1994; 65: 243-56.
128. Rosenheck, R., Gallup, P. and Frisman, L. K. Health care utilization and costs after entry into an outreach program for homeless mentally ill veterans. Hospital and Community Psychiatry 1993; 44: 1166-71.
129. Cormack, M. A., Sweeney, K. G., Hughes-Jones, H. and Foot, G. A. Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. British Journal of General Practice 1994; 44: 5-8.
130. Ginsberg, G., Marks, I. and Waters, H. Cost-benefit analysis of a controlled trial of nurse therapy for neuroses in primary care. Psychological Medicine 1984; 14: 683-90.
131. Prien, R. F., Gillis, R. D. and Caffey, E. M. Intermittent pharmacotherapy in chronic schizophrenia. Hospital and Community Psychiatry 1973; 24: 317-22.
132. Scott, A. I. and Freeman, C. P. L. Edinburgh primary care depression study: treatment outcome, patient satisfaction and costs after 16 weeks. British Medical Journal 1992; 304: 883-7.
133. Shapiro, J., Sank, L. I. and Shaffer, C. S. Cost-effectiveness of individual vs group cognitive behaviour therapy for problems of depression and anxiety in an HMO population. Journal of Clinical Psychology 1982; 38: 674-7.
134. Davies, L. M. and Drummond, M. F. Assessment of costs and benefits of drug therapy for treatment-resistant schizophrenia in the United Kingdom. British Journal of Psychiatry 1993; 162: 38-42.
135. Meltzer, H. Y., Cola, P., Way, L., Thompson, P. A., Bastani, B., Davies, M. A. and Snitz, B. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. American Journal of Psychiatry 1993; 150: 1630-8.
136. Thornton, P. H., Goldman, H. H., Stegner, B. L., Rappaport, M., Sorensen, J. E. and Attkisson, C. C. Assessing the costs and outcomes together-cost-effectiveness of two systems of acute psychiatric care. Evaluation and Program Planning 1990; 13: 231-41.
137. Coursey, R. D., Ward-Alexander, L. and Katz, B. Cost-effectiveness of providing insurance benefits for posthospital psychiatric halfway house stays. American Psychologists 1990; 45: 1118-26.
138. Sturm, R. and Wells, K. B. How can care for depression become more cost-effective? Journal of the American Medical Association 1995; 273: 51-8.
139. Karon, B. P. and Vandenbos, G. R. Cost-benefit analysis: psychologist versus psychiatrist for schizophrenia. Professional Psychology 1976; 7: 107-11.
140. Layde P. M., Von Allmen S. D. and Oakley G. P. Congenital hypothyroidism control programs, a cost-benefit analysis. Journal of the American Medical Association 1979; 241: 2290-92.
141. Frank, P. J., Klein, S. and Jacobs, J. Cost-benefit analysis of behavioral program for geriatric inpatients. Hospital and Community Psychiatry 1982; 33: 374-77.
142. Guyatt, G. H., Veldhuyzen Van Zanten, S., Feeny, D. H. and Patrick D. L. Measuring quality of life in clinical trials: a taxonomy and review. Canadian Medical Association Journal 1989; 140: 1441-48.
143. Rice, D. P. The Economic Costs of Alcohol and Drug Abuse and Mental Illness. Rockville, MD: National Institute of Mental Health, DHHS Publication No (ADM) 90-1694, 1990.
144. Kuldau, J. M. and Stanley, J. D. Controlled evaluation of a hospital-originated community transitional system. Archives of General Psychiatry 1977; 34: 1331-40.
145. Mangen, S. P., Paykel, E. E., Griffith, J. H., Burchell, A. and Mancini, P. Cost-effectiveness of community psychiatric nurse or out-patient psychiatrist care of neurotic patients. Psychological Medicine 1983; 13: 407-16.
146. Marriott, P. and Hiep, A. A mirror image out-patient study at a depot phenothiazine clinic. Australian and New Zealand Journal of Psychiatry 1976; 10: 163-7.
147. May, P. R. A. Cost-efficiency of treatments for the schizophrenic patient. American Journal of Psychiatry 1971; 127: 1382-5.
148. Andrews, G. The cost of schizophrenia revisited. Schizophrenia Bulletin 1991; 17: 389-94.
149. McCombs, J. S., Nichol, M. B., Stimmel, G. L., Sclar, D. A., Beasly, C. M. and Gross, L. S. The cost of antidepressant drug therapy failure: A study of antidepressant use patterns in a Medicaid population. Journal of Clinical Psychiatry 1990; 51: 60-9 supplement.
150. Wimo, A., Wallin, J. O., Lundgren, K., Rönnbäck, E., Asplund, K., Mattson, B. and Krakau, I. Group living, an alternative for dementia patients: a cost analysis. International Journal of Geriatric Psychiatry 1991; 6: 21-9.
151. Lindholm, H. and Ljungberg, L. Comparison of conventional neuroleptic therapy with depot neuroleptics, an attempt at economic evaluation. Acta Psychiatrica Scandinavica 1973; S246: 52-63.
152. Preskorn, S. H. and Fast, G. A. Therapeutic drug monitoring for antidepressants: efficacy, safety and cost-effectiveness. Journal of Clinical Psychiatry 1991; 52: 23-33.
153. Shemo, J. P. D. Cost-effectiveness of providing mental health services: the offset effect. International Journal of Psychiatry in Medicine 1985; 15: 19-30.
154. Terkelsen, K. G. and Grosser, R. C. Estimating clozapine's cost to the nation. Hospital and Community Psychiatry 1990; 41: 863-9.
155. Linn, M. W. Day treatment and psychotropic drugs in aftercare of schizophrenic patients: A veterans administration cooperative study. Archives of General Psychiatry 1979; 36: 1055-66.
156. Muller, C. F. and Caton, C. L. M. Economic costs of schizophrenia, a postdischarge study. Medical Care 1983; 11: 92-104.
157. Finkler, S. A. The distinction between cost and charges. Annals of Internal Medicine 1982; 96: 102-9.
158. Luce, B. and Elixhauser, A. Estimating costs in the economic evaluation of medical technologies. International Journal of Technology Assessment in Health Care 1990; 6: 57-75.
159. Maynard, A. The design of future cost-benefit studies. American Heart Journal 1990; 119: 761-5.
160. Ganiats, T. G. and Wong, A. F. Evaluation of cost-effectiveness research: a survey of recent publications. Family Medicine 1991; 23: 457-62.
161. Fried, B. J., Worthington, C. and Deber, R. B. Economic evaluations in the Canadian mental health system I: theory behind economic evaluation. Canadian Journal of Psychiatry 1989; 34: 633-6.